Maccura Biotechnology Co.Ltd (SHE:300463)

China flag China · Delayed Price · Currency is CNY
11.53
+0.10 (0.87%)
Mar 10, 2026, 12:55 PM CST
-15.22%
Market Cap 6.91B
Revenue (ttm) 2.21B
Net Income (ttm) -117.46M
Shares Out 604.67M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE 25.40
Dividend 0.10 (0.91%)
Ex-Dividend Date May 28, 2025
Volume 3,642,800
Average Volume 8,955,410
Open 11.23
Previous Close 11.43
Day's Range 11.23 - 11.58
52-Week Range 10.90 - 15.40
Beta 0.34
RSI 43.07
Earnings Date Apr 29, 2026

About SHE:300463

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including... [Read more]

Sector Healthcare
Founded 1994
Employees 3,106
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300463
Full Company Profile

Financial Performance

In 2024, SHE:300463's revenue was 2.55 billion, a decrease of -11.98% compared to the previous year's 2.90 billion. Earnings were 126.81 million, a decrease of -59.44%.

Financial Statements

News

There is no news available yet.